Report cover image

Omni-channel Retail Solutions Market Share, Size, Trends, Industry Analysis Report, By Offering (Solutions, Services); By Solution; By Services; By Region; Segment Forecast, 2022 - 2030

Published Sep 01, 2025
Length 118 Pages
SKU # PLRS20470311

Description

The global omni-channel retail solutions market size is expected to reach USD 25.76 billion by 2034, according to a new study by Polaris Market Research. The report “Omni-channel Retail Solutions Market Share, Size, Trends, Industry Analysis Report, By Offering (Solutions, Services); By Solution; By Services; By Region; Segment Forecast, 2025 - 2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

E-commerce is becoming increasingly popular in both developed and developing countries around the world. With burgeoning internet penetration and increased smartphone adoption, global sales via the online platform are on a strong growth trajectory. As one of the major channels in the omni-channel commerce platform ecosystem, e-commerce has a direct impact on the growth of the global market.

Top retailers have already adopted the retail omni-channel commerce platform to provide their customers with a seamless shopping experience. With advanced technologies and resources readily available today, small and medium-sized retailers are expected to begin investing in this software in order to compete in the global market.

Furthermore, widespread internet penetration has had a positive impact on the retail industry by increasing the global e-Commerce market. To compete with the leading and well-established top e-tailers, retailers will need to implement a strong multichannel commerce platform that connects their physical store with their own online channel. End-to-end integration of online/offline stores, dynamic order allocation, integrated multichannel order management, centralized inventory management, simplified logistics, and convenient return management are some of the key benefits of the omnichannel commerce platform.

Furthermore, the platform integrates seamlessly with ERPs and can generate data regularly, supporting an analytical approach. Some focus areas that could potentially improve omni-channel retail platforms are effective internal organization, adequate customer analytics capabilities, data quality, and the ability to identify customers across shopping trips.

Given the significant benefits of an omnichannel strategy, an increasing number of retailers are looking to establish a presence in multiple channels rather than limiting themselves to online or store formats.

The introduction of several digital touchpoints, such as smart shelf technologies, self-service tablets, and interactive kiosks, has disrupted the retail industry in recent years. As a result, omnichannel retail is emerging in a retail industry impacted by increased competition, the introduction of new technologies, and changing consumer behavior.

The rapid growth of e-commerce sales worldwide is one of the major factors influencing growth in the global market. Growing penetration of low-cost Internet services, as well as a rapid increase in sales and use of mobile devices, particularly smartphones, are major contributors to rising retail sales via online channels.

Because e-Commerce is regarded as one of the key channels in the omnichannel commerce ecosystem, the e-commerce industry's rapid growth has significant positive implications for the retail omni-channel commerce platform market. Several leading retailers are implementing retail omnichannel strategies to capitalize on the e-commerce opportunity while also driving traffic.

Omni-channel Retail Solutions Market Report Highlights

Solution segment held the largest market share in the offering segment as the demand for CRM software is rising with rising entrepreneurship.

Order management held the largest segment in the solutions segment with a rising need for accurate data, which is useful for point of sales and e-commerce.

Professional services held the largest sector as there is a rising need for integration and installation services in expanding e-commerce industry.

North America held the dominant position in the regional segment because of rising tech startups and e-commerce dominance.

Major players operating in the industry include NCR Corporation; Diebold Nixdorf AG; Infosys Ltd.; Toshiba Corporation; Oracle Corporation; SAP SE; IBM Corporation; Cognizant Technology Solutions Corp.; Salesforce, Inc.; Infor Global Solutions, Inc.

Polaris Market Research has segmented the omni-channel retail solutions market report based on offering, solution, services and region:

Omni-channel Retail Solutions, Offering Outlook (Revenue - USD Billion, 2020 - 2034)

Solutions

Services

Omni-channel Retail Solutions, Solution Outlook (Revenue - USD Billion, 2020 - 2034)

Order Management

Point of Sale

CRM

Warehouse/Inventory Management

Omni-channel Retail Solutions, Services Outlook (Revenue - USD Billion, 2022 – 2030)

Managed Services

Professional Services

Omni-channel Retail Solutions, Regional Outlook (Revenue - USD Billion, 2020 - 2034)

North America

U.S

Canada

Europe

Germany

UK

France

Italy

Spain

Asia Pacific

Japan

China

India

Australia

South Korea

Latin America

Brazil

Mexico

Argentina

Middle East & Africa

South Africa

Saudi Arabia

UAE

Table of Contents

118 Pages
1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
2. Executive Summary
2.1. Market Highlights
3. Research Methodology
3.1. Overview
3.1.1. Data Mining
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources
4. Global Epigenetics Market Insights
4.1. Epigenetics Market – Market Snapshot
4.2. Epigenetics Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Increasing Focus on Cancer Research and Personalized Medicine
4.2.1.2. Technological Advances in Epigenetic Analysis
4.2.2. Restraints and Challenges
4.2.2.1. Lack of Standardized Protocols and Interpretation
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Epigenetics Market Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis
5. Global Epigenetics Market, by Product
5.1. Key Findings
5.2. Introduction
5.2.1. Global Epigenetics Market, by Product, 2020–2034 (USD Billion)
5.3. Kits & Reagents
5.3.1. Global Epigenetics Market, by Kits & Reagents, by Region, 2020–2034 (USD Billion)
5.4. Enzymes
5.4.1. Global Epigenetics Market, by Enzymes, by Region, 2020–2034 (USD Billion)
5.5. Equipment & Accessories
5.5.1. Global Epigenetics Market, by Equipment & Accessories, by Region, 2020–2034 (USD Billion)
5.6. Software
5.6.1. Global Epigenetics Market, by Software, by Region, 2020–2034 (USD Billion)
5.7. Service
5.7.1. Global Epigenetics Market, by Service, by Region, 2020–2034 (USD Billion)
6. Global Epigenetics Market, by Technology
6.1. Key Findings
6.2. Introduction
6.2.1. Global Epigenetics Market, by Technology, 2020–2034 (USD Billion)
6.3. DNA Methylation
6.3.1. Global Epigenetics Market, by DNA Methylation, by Region, 2020–2034 (USD Billion)
6.4. Histone Methylation
6.4.1. Global Epigenetics Market, by Histone Methylation, by Region, 2020–2034 (USD Billion)
6.5. Histone Acetylation
6.5.1. Global Epigenetics Market, by Histone Acetylation, by Region, 2020–2034 (USD Billion)
6.6. Large non-coding RNA
6.6.1. Global Epigenetics Market, by Large non-coding RNA, by Region, 2020–2034 (USD Billion)
6.7. MicroRNA modification
6.7.1. Global Epigenetics Market, by MicroRNA modification, by Region, 2020–2034 (USD Billion)
6.8. Chromatin structures
6.8.1. Global Epigenetics Market, by Chromatin structures, by Region, 2020–2034 (USD Billion)
7. Global Epigenetics Market, by Application
7.1. Key Findings
7.2. Introduction
7.2.1. Global Epigenetics Market, by Application, 2020–2034 (USD Billion)
7.3. Oncology
7.3.1. Global Epigenetics Market, by Oncology, by Region, 2020–2034 (USD Billion)
7.4. Metabolic Disorders
7.4.1. Global Epigenetics Market, by Metabolic Disorders, by Region, 2020–2034 (USD Billion)
7.5. Immunology
7.5.1. Global Epigenetics Market, by Immunology, by Region, 2020–2034 (USD Billion)
7.6. Developmental Biology
7.6.1. Global Epigenetics Market, by Developmental Biology, by Region, 2020–2034 (USD Billion)
7.7. Cardiovascular Diseases
7.7.1. Global Epigenetics Market, by Cardiovascular Diseases, by Region, 2020–2034 (USD Billion)
7.8. Others
7.8.1. Global Epigenetics Market, by Others, by Region, 2020–2034 (USD Billion)
8. Global Epigenetics Market, by End-use
8.1. Key Findings
8.2. Introduction
8.2.1. Global Epigenetics Market, by End-use, 2020–2034 (USD Billion)
8.3. Academic Research
8.3.1. Global Epigenetics Market, by Academic Research, by Region, 2020–2034 (USD Billion)
8.4. Clinical Research
8.4.1. Global Epigenetics Market, by Clinical Research, by Region, 2020–2034 (USD Billion)
8.5. Hospitals & Clinics
8.5.1. Global Epigenetics Market, by Hospitals & Clinics, by Region, 2020–2034 (USD Billion)
8.6. Pharmaceutical & Biotechnology Companies
8.6.1. Global Epigenetics Market, by Pharmaceutical & Biotechnology Companies, by Region, 2020–2034 (USD Billion)
8.7. Other Users
8.7.1. Global Epigenetics Market, by Other Users, by Region, 2020–2034 (USD Billion)
9. Global Epigenetics Market, by Geography
9.1. Key Findings
9.2. Introduction
9.2.1. Epigenetics Market Assessment, By Geography, 2020–2034 (USD Billion)
9.3. Epigenetics Market – North America
9.3.1. North America: Epigenetics Market, by Product, 2020–2034 (USD Billion)
9.3.2. North America: Epigenetics Market, by Technology, 2020–2034 (USD Billion)
9.3.3. North America: Epigenetics Market, by Application, 2020–2034 (USD Billion)
9.3.4. North America: Epigenetics Market, by End-use, 2020–2034 (USD Billion)
9.3.5. Epigenetics Market – US
9.3.5.1. US: Epigenetics Market, by Product, 2020–2034 (USD Billion)
9.3.5.2. US: Epigenetics Market, by Technology, 2020–2034 (USD Billion)
9.3.5.3. US: Epigenetics Market, by Application, 2020–2034 (USD Billion)
9.3.5.4. US: Epigenetics Market, by End-use, 2020–2034 (USD Billion)
9.3.6. Epigenetics Market – Canada
9.3.6.1. Canada: Epigenetics Market, by Product, 2020–2034 (USD Billion)
9.3.6.2. Canada: Epigenetics Market, by Technology, 2020–2034 (USD Billion)
9.3.6.3. Canada: Epigenetics Market, by Application, 2020–2034 (USD Billion)
9.3.6.4. Canada: Epigenetics Market, by End-use, 2020–2034 (USD Billion)
9.4. Epigenetics Market – Europe
9.4.1. Europe: Epigenetics Market, by Product, 2020–2034 (USD Billion)
9.4.2. Europe: Epigenetics Market, by Technology, 2020–2034 (USD Billion)
9.4.3. Europe: Epigenetics Market, by Application, 2020–2034 (USD Billion)
9.4.4. Europe: Epigenetics Market, by End-use, 2020–2034 (USD Billion)
9.4.5. Epigenetics Market – UK
9.4.5.1. UK: Epigenetics Market, by Product, 2020–2034 (USD Billion)
9.4.5.2. UK: Epigenetics Market, by Technology, 2020–2034 (USD Billion)
9.4.5.3. UK: Epigenetics Market, by Application, 2020–2034 (USD Billion)
9.4.5.4. UK: Epigenetics Market, by End-use, 2020–2034 (USD Billion)
9.4.6. Epigenetics Market – France
9.4.6.1. France: Epigenetics Market, by Product, 2020–2034 (USD Billion)
9.4.6.2. France: Epigenetics Market, by Technology, 2020–2034 (USD Billion)
9.4.6.3. France: Epigenetics Market, by Application, 2020–2034 (USD Billion)
9.4.6.4. France: Epigenetics Market, by End-use, 2020–2034 (USD Billion)
9.4.7. Epigenetics Market – Germany
9.4.7.1. Germany: Epigenetics Market, by Product, 2020–2034 (USD Billion)
9.4.7.2. Germany: Epigenetics Market, by Technology, 2020–2034 (USD Billion)
9.4.7.3. Germany: Epigenetics Market, by Application, 2020–2034 (USD Billion)
9.4.7.4. Germany: Epigenetics Market, by End-use, 2020–2034 (USD Billion)
9.4.8. Epigenetics Market – Italy
9.4.8.1. Italy: Epigenetics Market, by Product, 2020–2034 (USD Billion)
9.4.8.2. Italy: Epigenetics Market, by Technology, 2020–2034 (USD Billion)
9.4.8.3. Italy: Epigenetics Market, by Application, 2020–2034 (USD Billion)
9.4.8.4. Italy: Epigenetics Market, by End-use, 2020–2034 (USD Billion)
9.4.9. Epigenetics Market – Spain
9.4.9.1. Spain: Epigenetics Market, by Product, 2020–2034 (USD Billion)
9.4.9.2. Spain: Epigenetics Market, by Technology, 2020–2034 (USD Billion)
9.4.9.3. Spain: Epigenetics Market, by Application, 2020–2034 (USD Billion)
9.4.9.4. Spain: Epigenetics Market, by End-use, 2020–2034 (USD Billion)
9.4.10. Epigenetics Market – Netherlands
9.4.10.1. Netherlands: Epigenetics Market, by Product, 2020–2034 (USD Billion)
9.4.10.2. Netherlands: Epigenetics Market, by Technology, 2020–2034 (USD Billion)
9.4.10.3. Netherlands: Epigenetics Market, by Application, 2020–2034 (USD Billion)
9.4.10.4. Netherlands: Epigenetics Market, by End-use, 2020–2034 (USD Billion)
9.4.11. Epigenetics Market – Russia
9.4.11.1. Russia: Epigenetics Market, by Product, 2020–2034 (USD Billion)
9.4.11.2. Russia: Epigenetics Market, by Technology, 2020–2034 (USD Billion)
9.4.11.3. Russia: Epigenetics Market, by Application, 2020–2034 (USD Billion)
9.4.11.4. Russia: Epigenetics Market, by End-use, 2020–2034 (USD Billion)
9.4.12. Epigenetics Market – Rest of Europe
9.4.12.1. Rest of Europe: Epigenetics Market, by Product, 2020–2034 (USD Billion)
9.4.12.2. Rest of Europe: Epigenetics Market, by Technology, 2020–2034 (USD Billion)
9.4.12.3. Rest of Europe: Epigenetics Market, by Application, 2020–2034 (USD Billion)
9.4.12.4. Rest of Europe: Epigenetics Market, by End-use, 2020–2034 (USD Billion)
9.5. Epigenetics Market – Asia Pacific
9.5.1. Asia Pacific: Epigenetics Market, by Product, 2020–2034 (USD Billion)
9.5.2. Asia Pacific: Epigenetics Market, by Technology, 2020–2034 (USD Billion)
9.5.3. Asia Pacific: Epigenetics Market, by Application, 2020–2034 (USD Billion)
9.5.4. Asia Pacific: Epigenetics Market, by End-use, 2020–2034 (USD Billion)
9.5.5. Epigenetics Market – China
9.5.5.1. China: Epigenetics Market, by Product, 2020–2034 (USD Billion)
9.5.5.2. China: Epigenetics Market, by Technology, 2020–2034 (USD Billion)
9.5.5.3. China: Epigenetics Market, by Application, 2020–2034 (USD Billion)
9.5.5.4. China: Epigenetics Market, by End-use, 2020–2034 (USD Billion)
9.5.6. Epigenetics Market – India
9.5.6.1. India: Epigenetics Market, by Product, 2020–2034 (USD Billion)
9.5.6.2. India: Epigenetics Market, by Technology, 2020–2034 (USD Billion)
9.5.6.3. India: Epigenetics Market, by Application, 2020–2034 (USD Billion)
9.5.6.4. India: Epigenetics Market, by End-use, 2020–2034 (USD Billion)
9.5.7. Epigenetics Market – Malaysia
9.5.7.1. Malaysia: Epigenetics Market, by Product, 2020–2034 (USD Billion)
9.5.7.2. Malaysia: Epigenetics Market, by Technology, 2020–2034 (USD Billion)
9.5.7.3. Malaysia: Epigenetics Market, by Application, 2020–2034 (USD Billion)
9.5.7.4. Malaysia: Epigenetics Market, by End-use, 2020–2034 (USD Billion)
9.5.8. Epigenetics Market – Japan
9.5.8.1. Japan: Epigenetics Market, by Product, 2020–2034 (USD Billion)
9.5.8.2. Japan: Epigenetics Market, by Technology, 2020–2034 (USD Billion)
9.5.8.3. Japan: Epigenetics Market, by Application, 2020–2034 (USD Billion)
9.5.8.4. Japan: Epigenetics Market, by End-use, 2020–2034 (USD Billion)
9.5.9. Epigenetics Market – Indonesia
9.5.9.1. Indonesia: Epigenetics Market, by Product, 2020–2034 (USD Billion)
9.5.9.2. Indonesia: Epigenetics Market, by Technology, 2020–2034 (USD Billion)
9.5.9.3. Indonesia: Epigenetics Market, by Application, 2020–2034 (USD Billion)
9.5.9.4. Indonesia: Epigenetics Market, by End-use, 2020–2034 (USD Billion)
9.5.10. Epigenetics Market – South Korea
9.5.10.1. South Korea: Epigenetics Market, by Product, 2020–2034 (USD Billion)
9.5.10.2. South Korea: Epigenetics Market, by Technology, 2020–2034 (USD Billion)
9.5.10.3. South Korea: Epigenetics Market, by Application, 2020–2034 (USD Billion)
9.5.10.4. South Korea: Epigenetics Market, by End-use, 2020–2034 (USD Billion)
9.5.11. Epigenetics Market – Australia
9.5.11.1. Australia: Epigenetics Market, by Product, 2020–2034 (USD Billion)
9.5.11.2. Australia: Epigenetics Market, by Technology, 2020–2034 (USD Billion)
9.5.11.3. Australia: Epigenetics Market, by Application, 2020–2034 (USD Billion)
9.5.11.4. Australia: Epigenetics Market, by End-use, 2020–2034 (USD Billion)
9.5.12. Epigenetics Market – Rest of Asia Pacific
9.5.12.1. Rest of Asia Pacific: Epigenetics Market, by Product, 2020–2034 (USD Billion)
9.5.12.2. Rest of Asia Pacific: Epigenetics Market, by Technology, 2020–2034 (USD Billion)
9.5.12.3. Rest of Asia Pacific: Epigenetics Market, by Application, 2020–2034 (USD Billion)
9.5.12.4. Rest of Asia Pacific: Epigenetics Market, by End-use, 2020–2034 (USD Billion)
9.6. Epigenetics Market – Middle East & Africa
9.6.1. Middle East & Africa: Epigenetics Market, by Product, 2020–2034 (USD Billion)
9.6.2. Middle East & Africa: Epigenetics Market, by Technology, 2020–2034 (USD Billion)
9.6.3. Middle East & Africa: Epigenetics Market, by Application, 2020–2034 (USD Billion)
9.6.4. Middle East & Africa: Epigenetics Market, by End-use, 2020–2034 (USD Billion)
9.6.5. Epigenetics Market – Saudi Arabia
9.6.5.1. Saudi Arabia: Epigenetics Market, by Product, 2020–2034 (USD Billion)
9.6.5.2. Saudi Arabia: Epigenetics Market, by Technology, 2020–2034 (USD Billion)
9.6.5.3. Saudi Arabia: Epigenetics Market, by Application, 2020–2034 (USD Billion)
9.6.5.4. Saudi Arabia: Epigenetics Market, by End-use, 2020–2034 (USD Billion)
9.6.6. Epigenetics Market – UAE
9.6.6.1. UAE: Epigenetics Market, by Product, 2020–2034 (USD Billion)
9.6.6.2. UAE: Epigenetics Market, by Technology, 2020–2034 (USD Billion)
9.6.6.3. UAE: Epigenetics Market, by Application, 2020–2034 (USD Billion)
9.6.6.4. UAE: Epigenetics Market, by End-use, 2020–2034 (USD Billion)
9.6.7. Epigenetics Market – Israel
9.6.7.1. Israel: Epigenetics Market, by Product, 2020–2034 (USD Billion)
9.6.7.2. Israel: Epigenetics Market, by Technology, 2020–2034 (USD Billion)
9.6.7.3. Israel: Epigenetics Market, by Application, 2020–2034 (USD Billion)
9.6.7.4. Israel: Epigenetics Market, by End-use, 2020–2034 (USD Billion)
9.6.8. Epigenetics Market – South Africa
9.6.8.1. South Africa: Epigenetics Market, by Product, 2020–2034 (USD Billion)
9.6.8.2. South Africa: Epigenetics Market, by Technology, 2020–2034 (USD Billion)
9.6.8.3. South Africa: Epigenetics Market, by Application, 2020–2034 (USD Billion)
9.6.8.4. South Africa: Epigenetics Market, by End-use, 2020–2034 (USD Billion)
9.6.9. Epigenetics Market – Rest of Middle East & Africa
9.6.9.1. Rest of Middle East & Africa: Epigenetics Market, by Product, 2020–2034 (USD Billion)
9.6.9.2. Rest of Middle East & Africa: Epigenetics Market, by Technology, 2020–2034 (USD Billion)
9.6.9.3. Rest of Middle East & Africa: Epigenetics Market, by Application, 2020–2034 (USD Billion)
9.6.9.4. Rest of Middle East & Africa: Epigenetics Market, by End-use, 2020–2034 (USD Billion)
9.7. Epigenetics Market – Latin America
9.7.1. Latin America: Epigenetics Market, by Product, 2020–2034 (USD Billion)
9.7.2. Latin America: Epigenetics Market, by Technology, 2020–2034 (USD Billion)
9.7.3. Latin America: Epigenetics Market, by Application, 2020–2034 (USD Billion)
9.7.4. Latin America: Epigenetics Market, by End-use, 2020–2034 (USD Billion)
9.7.5. Epigenetics Market – Mexico
9.7.5.1. Mexico: Epigenetics Market, by Product, 2020–2034 (USD Billion)
9.7.5.2. Mexico: Epigenetics Market, by Technology, 2020–2034 (USD Billion)
9.7.5.3. Mexico: Epigenetics Market, by Application, 2020–2034 (USD Billion)
9.7.5.4. Mexico: Epigenetics Market, by End-use, 2020–2034 (USD Billion)
9.7.6. Epigenetics Market – Brazil
9.7.6.1. Brazil: Epigenetics Market, by Product, 2020–2034 (USD Billion)
9.7.6.2. Brazil: Epigenetics Market, by Technology, 2020–2034 (USD Billion)
9.7.6.3. Brazil: Epigenetics Market, by Application, 2020–2034 (USD Billion)
9.7.6.4. Brazil: Epigenetics Market, by End-use, 2020–2034 (USD Billion)
9.7.7. Epigenetics Market – Argentina
9.7.7.1. Argentina: Epigenetics Market, by Product, 2020–2034 (USD Billion)
9.7.7.2. Argentina: Epigenetics Market, by Technology, 2020–2034 (USD Billion)
9.7.7.3. Argentina: Epigenetics Market, by Application, 2020–2034 (USD Billion)
9.7.7.4. Argentina: Epigenetics Market, by End-use, 2020–2034 (USD Billion)
9.7.8. Epigenetics Market – Rest of Latin America
9.7.8.1. Rest of Latin America: Epigenetics Market, by Product, 2020–2034 (USD Billion)
9.7.8.2. Rest of Latin America: Epigenetics Market, by Technology, 2020–2034 (USD Billion)
9.7.8.3. Rest of Latin America: Epigenetics Market, by Application, 2020–2034 (USD Billion)
9.7.8.4. Rest of Latin America: Epigenetics Market, by End-use, 2020–2034 (USD Billion)
10. Competitive Landscape
10.1. Expansion and Acquisition Analysis
10.1.1. Expansion
10.1.2. Acquisitions
10.2. Partnerships/Collaborations/Agreements/Exhibitions
11. Company Profiles
11.1. Active Motif
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Product Benchmarking
11.1.4. Recent Development
11.2. Agilent Technologies, Inc.
11.2.1. Company Overview
11.2.2. Financial Performance
11.2.3. Product Benchmarking
11.2.4. Recent Development
11.3. Bio-Rad Laboratories, Inc.
11.3.1. Company Overview
11.3.2. Financial Performance
11.3.3. Product Benchmarking
11.3.4. Recent Development
11.4. Diagenode S.A.
11.4.1. Company Overview
11.4.2. Financial Performance
11.4.3. Product Benchmarking
11.4.4. Recent Development
11.5. EpiGentek Group Inc.
11.5.1. Company Overview
11.5.2. Financial Performance
11.5.3. Product Benchmarking
11.5.4. Recent Development
11.6. Illumina, Inc.
11.6.1. Company Overview
11.6.2. Financial Performance
11.6.3. Product Benchmarking
11.6.4. Recent Development
11.7. Merck KGaA
11.7.1. Company Overview
11.7.2. Financial Performance
11.7.3. Product Benchmarking
11.7.4. Recent Development
11.8. New England Biolabs, Inc.
11.8.1. Company Overview
11.8.2. Financial Performance
11.8.3. Product Benchmarking
11.8.4. Recent Development
11.9. PerkinElmer, Inc.
11.9.1. Company Overview
11.9.2. Financial Performance
11.9.3. Product Benchmarking
11.9.4. Recent Development
11.10. QIAGEN N.V.
11.10.1. Company Overview
11.10.2. Financial Performance
11.10.3. Product Benchmarking
11.10.4. Recent Development
11.11. Thermo Fisher Scientific Inc.
11.11.1. Company Overview
11.11.2. Financial Performance
11.11.3. Product Benchmarking
11.11.4. Recent Development
11.12. Zymo Research Corporation
11.12.1. Company Overview
11.12.2. Financial Performance
11.12.3. Product Benchmarking
11.12.4. Recent Development
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.